蜂巢玻尿酸e.p.t.q. S300

e.p.t.q. S300 with Lidocaine

蜂巢玻尿酸e.p.t.q. S300 是一種含有利多卡因的交聯透明質酸（HA）真皮填充劑，由…製造。 Jetema Co., Ltd. of South Korea. It is the medium-firmness gel in the e.p.t.q. range, balancing firmness and spreadability, and is intended for the mid to deep dermis to address lines and folds. For use by licensed healthcare professionals only.

主要特點

• HIVE 結構：製造商將大小均勻的透明質酸（HA）顆粒壓縮成一種緻密、分佈均勻的蜂窩狀結構。這種由均勻顆粒構成的設計，旨在確保凝膠在註射器內及注入組織後，均能呈現出更穩定一致的性能表現。
• 減少交聯劑用量：該製造商所採用的交聯製程旨在減少 BDDE 的使用量，同時保持凝膠的彈性。
• Medium Gel Firmness: The middle gel of the three e.p.t.q. gels, balancing firmness and spreadability for mid to deep dermal placement.
• 含利多卡因：含有利多卡因，有助於減輕注射過程中的不適感。
• Pre-Filled Syringe: 1.1 ml, supplied with 27G needles.

為何顆粒均勻性至關重要

A gel with widely varying particle sizes may give uneven extrusion force within the same syringe and less predictable distribution in tissue. Uniform particles give a more consistent gel texture, which helps the practitioner control small volumes at different depths.

這描述的是一種材料設計概念。但這並不代表其效果優於其他品牌。最終效果取決於醫師對治療區域、深度及容量的評估。

e.p.t.q. 系列對比

S100、S300 和 S500 之間的差異在於交聯後的凝膠硬度，而非濃度。每支注射器均對應特定的注射深度，醫師會根據治療層次選擇適當的凝膠。

• e.p.t.q. S100：硬度較低。適用於真皮淺層，用於改善細紋及進行精細矯正。
• e.p.t.q. S300：中等硬度。適用於真皮中層至深層，針對皺紋和褶皺。
• e.p.t.q. S500：硬度高。適用於皮下或骨膜上層注射，旨在增加容量並提供支撐。

預期用途

• Moderate to deeper wrinkles in the mid to deep dermis
• Nasolabial folds
• Marionette lines
• Perioral wrinkles

具體的治療部位、注射深度、操作手法及注射劑量，必須遵循官方《使用說明書》（IFU）並結合主診醫師的評估。治療效果及維持時間因人而異。

產品規格

• 品牌： e.p.t.q. (epitique)
• Product: e.p.t.q. S300 Lidocaine
• 製造商： Jetema Co., Ltd., South Korea
• Composition: Cross-linked hyaluronic acid gel with lidocaine
• Technology: HIVE structure
• Gel Firmness: Medium (middle of the e.p.t.q. range)
• Contents: 1 × 1.1 ml pre-filled syringe, 27G needles
• 產品類型： Hyaluronic acid dermal filler (medical device)
• 起源： South Korea

施用

• For use only by licensed healthcare professionals trained in dermal filler injection, facial vascular anatomy and the management of filler complications.
• Injection depth, technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

預防措施

• Common reactions include redness, swelling, tenderness, bruising and small lumps at the injection site.
• Product placed too superficially may cause visible lumps or a bluish discoloration (Tyndall effect).
• Accidental injection into a blood vessel can cause vascular occlusion, which may lead to skin necrosis or, rarely, vision loss.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately if there is severe pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Keep out of reach of children.

Who Should Consult a Physician First

• People with known allergy to hyaluronic acid, lidocaine or amide-type local anaesthetics
• Pregnant or breastfeeding women
• People with infection, inflammation, cold sores or skin disease at the treatment area
• People with bleeding disorders or taking medicines that affect blood clotting
• People with autoimmune disease, a history of keloids or severe allergies
• People with facial implants or permanent fillers in the treatment area
• People under 18 years of age

貯存

Store according to the instructions on the carton and in the IFU. Do not freeze. Protect from direct sunlight. Refer to the carton for the expiry date.

Package Contents

• 1 × 1.1 ml pre-filled syringe of e.p.t.q. S300 Lidocaine
• 27G needles
• Instructions for Use

重要通知

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.